Chinese Journal of Pharmacovigilance ›› 2018, Vol. 15 ›› Issue (8): 499-500.
Previous Articles Next Articles
WANG Ying, CUI Xiangli*, LIU Lihong
Received:2018-10-11
Revised:2018-10-11
Online:2018-08-20
Published:2018-10-11
CLC Number:
WANG Ying, CUI Xiangli, LIU Lihong. One Case of Mental Abnormality Induced by Drug Interaction[J]. Chinese Journal of Pharmacovigilance, 2018, 15(8): 499-500.
| [1] 赵晶,周颖,崔一民,等. 129例伏立康唑致精神症状不良反应分析[J]. 临床药物治疗杂志,2016,14(4):67-71. [2] 陈美兰,童秀珍,李娟,等. 伏立康唑引起精神症状6例临床分析[J]. 中国神经精神疾病杂志, 2014,40(8):483-485. [3] 胡琴,刘维,邵宏. 伏立康唑联用糖皮质激素致谵妄1例[J]. 药品评价, 2015,12(10):41-44. [4] Pascual A, Calandra T, Bolay S, et al.Voriconazoletherapeutic drug monitoring in patients with invasive mycoses improves efficacyand safety outcomes[J]. Clin Infect Dis, 2008,46(2):201-211. [5] Boyd A E, Modi S, Howard S J, et al.Adverse reactionsto voriconazole[J]. Clin Infect Dis, 2004,39(8):1241-1244. [6] 杨海,赵海. 奥美拉唑诱发精神异常1例[J]. 中国药物警戒, 2012,9(10):639. [7] 刘波,姚鸿萍. 临床常用质子泵抑制剂的研究进展[J]. 西北药学杂志, 2014,29(3):328-332. [8] Yang H X, Chen K, Liang S Y, et al.Effect of cytochrome P-450 inhibitors on pharmacokinetics and safety of voriconazole[J]. J Chin Pharm Sci, 2017,26(3),202-211. [9] 付丽芳,赖善城. 药物引起神经精神症状不良反应文献统计分析[J].西藏医药杂志, 2011,3(4):52-53. [10] 钟古华,廖君兰,廖小凤,等. 糖皮质激素导致精神症状影响因素分析[J]. 国际精神病学杂志, 2016,43(5),809-812. [11] 万志龙,刘明亮. 莫西沙星的安全性评价[J]. 国外医药抗生素分册, 2006,27(3):105-109. |
| [1] | SUN Qiyue, ZHAO Ronghua, GUO Shanshan, BAO Lei, GENG Zihan, LI Shuran, XU Yingli, ZHANG Jingsheng, CUI Xiaolan, SUN Jing. Multiple pharmacological effects of Lingyang Ganmao Oral Liquid [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 127-131. |
| [2] | ZHAO Ronghua, SUN Jing, BAO Lei, GENG Zihan, TAO Xiali, ZHANG Jingsheng, PANG Bo, XU Yingli, CAO Shan, LI Shuran, GUO Shanshan, WANG Daohan, CUI Xiaolan. Mechanisms of Gegen Tang granules against viral pneumonia in mice based on immune regulation [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 132-136. |
| [3] | BAO Lei, GENG Zihan, LI Shuran, JI Zuen, ZHAO Ronghua, SUN Jing, GUO Shanshan, CUI Xiaolan. The critical role of TRP channels in the progression of viral pneumonia [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 137-140. |
| [4] | JIA Jinsheng, LIU Hongliang, WANG Qing, HOU Yongfang, LI Xinling. Evaluation of the relevance of adverse drug reaction based on ERNIE-DPCNN [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 163-166. |
| [5] | LI Jiaxin, LIU Huimin, QIAN Wenxiu, MA Ning, SONG Lili, LI Yubo. Nephrotoxic effects and usage of traditional Chinese medicines based on the Traditional Chinese Medicine Systems Toxicology Database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 173-180. |
| [6] | FAN Kaikai, WANG Cong, LIU Hongfeng, WANG Xiyong. Effects of clinical pharmacist interventions on usage of alanyl-glutamine injections in a hospital [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 181-184. |
| [7] | ZHANG Jian, FANG Huihua. Applicability of evaluation standards for use of traditional Chinese medicine injections for promoting blood circulation and removing blood stasis [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 185-189. |
| [8] | WANG Shan, XIE Bo, LIU Huimin, LI Zhihao. Adverse event signals for celecoxib based on FAERS database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 190-194. |
| [9] | LI Yingfen, HAN Lei. Analysis of 319 cases of adverse drug reaction induced by cerebroprotein hydrolysate for injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 195-198. |
| [10] | XU Weijia, PENG Qi, HUANG Haiyu, ZHANG Leijiao, XIAO Hua, WU Xue. 285 cases of adverse drug reaction related to new antineoplastic drugs [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 199-203. |
| [11] | GUO Qinghua, PENG Xiaoxiao, ZHU Ping, LIU Xilin, YANG Yinghua, CHEN Zhihai. One case of multiple organ dysfunction syndrome caused by amlodipine overdose [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 204-207. |
| [12] | FANG Meilin, ZHENG Huimin, WANG Cunze, WANG Ling, RUAN Junshan. One case of generalized myalgia caused by oxaliplatin [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 208-210. |
| [13] | LI Na, GUO Jun, GUO Wenjia, LYU Yinyin, LI Caihong, MU Xiangdong. One case of delayed skin allergic reaction caused by asthma treated with omalizumab injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 211-212. |
| [14] | CAO Guiping, DENG Linlin, ZHU Ganhong, LU Ying, MA Shuang, CHEN Linlin, Liu Lili. One case of severe liver injury caused by Tianma Shouwu tablets [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 216-218. |
| [15] | ZHU Ying, SHEN Lu, LI Lan, WU Jianmin, GAO Xiaojie. Adverse reaction monitoring of toothpaste in China under the new regulatory system [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 219-222. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
